Comparison of the efficacy of 10 day-triple therapy-based, bismuth-containing quadruple therapy including lansoprazole with esomeprazole for the first line therapy of Helicobacter pylori

被引：0
|
作者：
Moon, B. S. [1 ]
Lim, H. [1 ]
Lee, S. [1 ]
Lee, Y. [2 ]
机构：
[1] Yonsei Univ, Yongin Severance Hosp, Seoul, South Korea
[2] Yonsei Univ, Severance Hosp, Seoul, South Korea
来源：
HELICOBACTER | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.49
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
    Gisbert, J. P.
    Romano, M.
    Gravina, A. G.
    Solis-Munoz, P.
    Bermejo, F.
    Molina-Infante, J.
    Castro-Fernandez, M.
    Ortuno, J.
    Lucendo, A. J.
    Herranz, M.
    Modolell, I.
    del Castillo, F.
    Gomez, J.
    Barrio, J.
    Velayos, B.
    Gomez, B.
    Dominguez, J. L.
    Miranda, A.
    Martorano, M.
    Algaba, A.
    Pabon, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Federico, A.
    Marin, A. C.
    McNicholl, A. G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 768 - 775
  • [32] The Efficacy of Bismuth Quadruple Therapy, Sequential Therapy, and Hybrid Therapy as a First-Line Regimen for Helicobacter pylori Infection Compared with Standard Triple Therapy
    Koroglu, M.
    Ayvaz, M. A.
    Ozturk, M. A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2022, 25 (09) : 1535 - 1541
  • [33] Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
    Dore, Maria Pina
    Farina, Valentina
    Cuccu, Marianna
    Mameli, Laura
    Massarelli, Giovanni
    Graham, David Y.
    HELICOBACTER, 2011, 16 (04) : 295 - 300
  • [34] Inefficacy of Triple Therapy and Comparison of Two Different Bismuth-containing Quadruple Regimens as a Firstline Treatment Option for Helicobacter pylori
    Kekilli, Murat
    Onal, Ibrahim K.
    Ocal, Serkan
    Dogan, Zeynal
    Tanoglu, Alpaslan
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (05): : 366 - 369
  • [35] 10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection
    Campillo, Ana
    Amorena, Edurne
    Ostiz, Miriam
    Kutz, Marcos
    Lalglesia, Matilde
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (09): : 584 - 589
  • [36] Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
    Lee, Seong Tae
    Lee, Dong Ho
    Lim, Ji Hyun
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Jo, Hyun Jin
    Song, In Sung
    GUT AND LIVER, 2015, 9 (04) : 478 - 485
  • [37] A modified Bismuth-Containing Quadruple Therapy Including a Short Course of Furazolidone for Helicobacter pylori Eradication After Sequential Therapy Failure
    Fakheri, Hafez
    Bari, Zohreh
    Sardarian, Hossein
    HELICOBACTER, 2012, 17 (04) : 264 - 268
  • [38] Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
    Wu, Cheng
    Chen, Xiao
    Liu, Jing
    Li, Ming-Yang
    Zhang, Zi-Qi
    Wang, Zhi-Qiang
    HELICOBACTER, 2011, 16 (02) : 131 - 138
  • [39] META-ANALYSIS OF LEVOFLOXACIN-CONTAINING TRIPLE THERAPY VERSUS BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT IN THE ERADICATION OF HELICOBACTER PYLORI
    Marin, A. C.
    McNicholl, A. G.
    Gisbert, J. P.
    HELICOBACTER, 2011, 16 : 132 - 132
  • [40] Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
    Aksoy, Evrim Kahramanoglu
    Sapmaz, Ferdane Pirincci
    Goktas, Zeynep
    Uzman, Metin
    Nazligul, Yasar
    MEDICAL PRINCIPLES AND PRACTICE, 2017, 26 (06) : 523 - 529
12345